Published analysis for 2027 points to AI moving toward workflow infrastructure, care shifting to lower-cost settings, value-based care still in pilots, security and AI governance shaping purchases, supply chain pressure and consolidation. For B2B teams, each trend changes the buying committee and the proof buyers ask for.
Healthcare buyers are being asked to do three hard things at once: adopt AI without adding risk, move care into cheaper settings without losing quality, and prove outcomes under payment models that reward results. For companies that sell to them, each shift changes who is in the buying committee, what proof they ask for and where you can meet them.
This guide summarises six trends that published industry analysis points to for 2027, explains what each means for B2B sales and partnership teams, and shows where to see them play out in person. We attribute each trend to the publication that describes it, and we separate those published views from our own recommendations.
Published views and recommendations. Trend descriptions below paraphrase reports by PwC and EY, named in each section. They are views from those publications, not forecasts we can guarantee. Event names, dates and venues come from organiser pages and event calendars checked on October 22, 2026, so confirm them before you book travel. Advice on what to do is ours.
Six trends shaping healthcare business in 2027
1. AI moves from pilots toward infrastructure
PwC’s Global Health Report describes AI becoming a form of infrastructure that embeds prediction into clinical and operational workflows, noting that most healthcare AI today still targets bounded tasks such as documentation, diagnostics and scheduling. For sellers: buyers will ask how your product fits their workflow and governance, not whether AI works in general. If you sell technology, our guide to AI and technology conferences covers the events where those conversations happen.
2. Care keeps moving to lower-cost settings
EY’s healthcare sector outlook cites volume migration to lower-cost care settings as an industry force, and PwC describes care moving closer to home. For sellers: products designed for hospital wards may need to work in ambulatory, home and virtual settings, and the buying committee may include payers and home-care operators as well as hospitals.
3. Value-based care is still mostly in pilots
PwC observes that most value-based initiatives remain limited to pilots, single conditions or local programmes rather than system-wide adoption. For sellers: expect buyers to ask for outcome evidence and to move in stages. Sales cycles built around pilots tend to be longer than single-purchase cycles, so plan for that.
4. Cybersecurity and AI governance shape buying
EY’s analysis of health care transformation lists data infrastructure concerns, cybersecurity risks, a lack of responsible AI standards and compliance risks among the barriers leaders cite to AI adoption. For sellers: security and governance questions arrive early in the process. Have documented answers ready before the first demo.
5. Supply chain and cost pressure
EY identifies supply chain complexity and the management of implant and supply expenses as live issues for providers. For sellers: distributors and procurement teams carry more weight, and resilience is a selling point. Our guide for medical equipment suppliers finding distributors covers the channel side.
6. Consolidation and partnership
EY expects value-based models to drive consolidation and integration across the sector. For sellers: fewer, larger buyers mean each relationship matters more, and partnerships can matter more than cold outreach.
Where to see these trends in person
Conferences are where these trends become visible: session titles show what buyers are worried about, and exhibitor categories show where vendors are investing. These events fall between now and mid-2027.
| Event | Dates | Where | What it shows you |
|---|---|---|---|
| HLTH 2026 | Nov 15–18, 2026 | Las Vegas, USA | Health systems, payers, digital health and investor partnerships |
| MEDICA 2026 | Nov 16–19, 2026 | Düsseldorf, Germany | Devices, diagnostics, laboratory equipment and health IT |
| RSNA 2026 | Nov 29–Dec 3, 2026 | Chicago, USA | Imaging, and a large AI showcase for radiology |
| WHX Dubai 2027 (formerly Arab Health) | Jan 25–28, 2027 | Dubai, UAE | Middle East and Africa procurement, devices and digital health |
| HIMSS27 | Apr 5–8, 2027 | Chicago, USA | Health IT, interoperability, cybersecurity and AI |
| ASCO 2027 | Jun 4–8, 2027 | Chicago, USA | Oncology pharma, diagnostics and clinical-trial technology |
VisitorsList’s Medical & Pharma events hub lists more shows by specialty and region.
What these trends mean for your B2B plan
- If you sell software or AI: lead with workflow fit, governance and security evidence. Name the role who owns each one.
- If you sell devices or equipment: show how the product performs outside the hospital, and prepare for distributors and procurement to be part of the decision.
- If you sell services: map the new buyers created by consolidation and by care moving to lower-cost settings.
- For every segment: use event participant and exhibitor lists to see who is investing in your category. Our guide to using attendee lists explains how.
Frequently asked questions
What are the biggest healthcare trends for 2027?
Published analysis from PwC and EY points to AI moving toward workflow infrastructure, care shifting to lower-cost and home settings, value-based care remaining largely in pilots, cybersecurity and AI governance as adoption barriers, supply chain pressure and consolidation.
Which healthcare events should B2B teams watch?
Which ones matter depends on your buyer. HLTH and HIMSS27 suit digital health and health IT, MEDICA and WHX Dubai suit devices and distribution, RSNA suits imaging, and ASCO suits oncology. Confirm dates on organiser sites.
How do these trends affect healthcare sales cycles?
Our view is that cycles are likely to involve more stakeholders, earlier security and governance review, and requests for outcome evidence. Ask each account to describe its own process rather than assuming one.
Do I need to exhibit to learn from a healthcare event?
No. Session programmes, exhibitor categories and participant lists show where buyers and competitors are focused, even if you never travel.
Mick Underwood
Sr Team Lead – Business Development, VisitorsListWrites about trade shows, event data and B2B prospecting for the VisitorsList blog. View profile →
